Literature DB >> 29420376

A Minimally Invasive Endoscopic Approach to Midcheek Mass: Showcase for Technical Description.

Vincenzo Abbate1, Giovanni Dell'Aversana Orabona1, Antonio Romano1, Fabio Maglitto1, Giorgio Iaconetta2, Luigi Califano1.   

Abstract

BACKGROUND: Surgical approaches to the midcheek area are challenging. This area is included between the lower eyelid above, and the upper lip below. The peculiar anatomical location makes it really important for attractiveness, thus the need to obtain a correct balance between the operation's safety and minimally invasive aspect. To the authors' knowledge, this is the first showcase and technical description of a novel minimally invasive endoscopic approach for midcheek mass removal.
METHODS: Making 3 incisions in concealed area an endoscopically aided facial dissection was performed to remove a solitary venus malformation of the left midcheek region.
RESULTS: After the surgical procedure was performed, no hematoma, no edema, or facial nerve paralysis were observed. To date, during the follow-up period, no recurrence of the lesion has been observed, and the quality of life of the patient was good with a minimally scar outcome. Magnetic resonance imaging, performed 2 weeks postoperatively, demonstrated a complete removal of the mass
CONCLUSION: : The authors' finding experience suggests that the minimally invasive approach provides an excellent surgical window that achieves greater exposure for the dissection of the midcheek area. Further clinical applications are required to assess advantages and/or limitations of this procedure.

Entities:  

Mesh:

Year:  2018        PMID: 29420376     DOI: 10.1097/SCS.0000000000004363

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  1 in total

1.  Special Issue "New Frontiers in Facial Surgery".

Authors:  Giovanni Dell'Aversana Orabona; Fabio Maglitto; Vincenzo Abbate; Antonio Romano; Paola Bonavolontà; Luigi Califano
Journal:  J Clin Med       Date:  2022-05-30       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.